MediCrops Stock
MediCrops develops pharmaceuticals intended to offer medical cannabis preparations containing tetrahydrocannabinol (THC). The company cultivates cannabis under a state-approved cultivation license, offering a wide collection of premium recreational cannabis products, enabling the medical community to conduct a wide range of treatments.
Management Team
| Ivan Mestrangelo Co-Founder, Co-Chief Executive Officer, and Chairman |
| Eva Vaoutsi Co-Chief Executive Officer |
| Luitpold Wüsthof Chief Financial Officer |
| Toby Shillito Chief Business Development Officer |
